| Document Date: 2013-09-10 08:43:00
Open Document File Size: 413,55 KBShare Result on Facebook
City CAMBRIDGE / / Company Novartis / Anida Pharma Anida Pharma Inc. / Biogen Idec / Anida Pharma Inc. / ALS TDI / / Country United States / / Currency USD / / Event FDA Phase / Funding / Business Partnership / / Facility About ALS Therapy Development Institute / ALS Therapy Development Institute / / IndustryTerm biopharmaceutical company developing novel first-in-class therapies / / MedicalCondition progressive neurodegenerative disease / paralysis / Lou Gehrig’s disease / disease / ALS / amyotrophic lateral sclerosis / Parkinson’s disease / multiple sclerosis / inflammation / hearing loss / central nervous system disorders / / Organization MDA / RGK Foundation / ALS Therapy Development Institute / Therapy Development Institute / / Person Per Gjorstrup / Steve Perrin / Lou Gehrig / / Position CEO / President and CEO / forward for additional preclinical testing / / Product TDI-132 / / ProvinceOrState Massachusetts / / Technology drug development / Apoptosis / / URL www.anidapharma.com / www.als.net / /
SocialTag |
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS